Compass Therapeutics, Inc. Share Price

Compass Therapeutics, Inc. Share Price

NASDAQ: CMPX | Micro Cap
$0.60
-$0.06 (-8.85%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Compass Therapeutics, Inc. Stock Performance

Open
$0.64
Prev. Close
$0.66
Circuit Range
N/A
Day Range
$0.57 - $0.65
Year Range
$0.57 - $6.86
Volume
1,90,436
Average Traded
$0.59

Compass Therapeutics, Inc. Share Price Today

As of 18 November 2026, Compass Therapeutics, Inc.'s share price is $0.60. The stock opened at $0.64, compared to its previous close of $0.66. During today's trading session, Compass Therapeutics, Inc.'s share price traded between $0.57 and $0.65, with an average price of $0.61. Over the past 52 weeks, the stock has recorded a high of $6.86 and a low of $0.57. In terms of performance, Compass Therapeutics, Inc.'s share price has declined by 74.85% over the last six months and is down 89.61% on a year-on-year basis.

Compass Therapeutics, Inc. Share Price Chart

Line chart of the Compass Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 0.57 to 0.65, ending at 0.60.
$0.57$0.65
L
Show Current Price
H

Compass Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$94.98M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-60.57%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-72.84%

Compass Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$15.72-$18.32-$25.15-$27.17
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-16.54%-37.28%-8.03%

Compass Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.85$0.00
Net Profit-$39.23-$42.49-$49.38-$66.49
Net Profit MarginN/AN/A-5809.41%N/A
Income ChangeN/A-8.31%-16.22%-34.65%

About Compass Therapeutics, Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Compass Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.81
$0.60
-24.21%
Oct 2026
$1.02
$0.79
-23.38%
Sep 2026
$2.36
$1.03
-59.01%
Aug 2026
$1.93
$2.52
+32.55%
Jul 2026
$2.19
$1.91
-12.81%
Jun 2026
$2.30
$2.19
-8.77%
May 2026
$1.78
$2.40
+34.55%
Apr 2026
$5.43
$1.78
-66.35%
Mar 2026
$5.38
$5.29
-6.21%
Feb 2026
$6.41
$5.64
-11.81%
Jan 2026
$5.36
$6.39
+19.09%
Dec 2025
$5.83
$5.37
-7.33%

CMPX Share Price FAQs